文献速递神经核医学肿瘤 PET/CT

验证[¹⁸F]SiTATE PET/CT中的SUV阈值用于准确分割脑膜瘤

Validation of SUV thresholds in [¹⁸F]SiTATE PET/CT for accurate meningioma segmentation.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-07-23

研究纳入61例患者109个脑膜瘤病灶,在[¹⁸F]SiTATE PET/CT上比较个体化最小SUV与固定阈值4.0的分割体积,中位最佳SUVmin为4.2,固定阈值4.0与个体化体积绝对一致性好(ICC[A,1]=0.967),但17个病灶(SUVmax<4.2)未被固定阈值捕获。

要点

  • 中位最佳病灶勾画SUVmin为4.2,骨受累对中位SUVmin无显著影响(p=0.1)。
  • 固定阈值4.0与个体化SUV体积绝对一致性好(ICC[A,1]=0.967;95%CI 0.952-0.977;p<0.0001)。
  • 17个病灶(SUVmax<4.2)未被固定阈值4.0捕获,其中主要为很小的病灶。

核心结论

  • 所提出的SUV阈值4.0显示出有前景的结果,支持其适用于临床实践。
  • 虽然存在局限,16%的病灶(主要为很小的病灶)摄取减低而未被该阈值捕获,但研究强调其在临床实践中的适用性。

研究设计与样本

  • 连续纳入已知或疑似脑膜瘤、接受[¹⁸F]SiTATE PET/CT和增强脑MRI的患者。
  • 在PET图像上于手动定义的感兴趣体积内以个体化最小SUV(SUVmin)半自动分割病灶,并利用配准CT和MRI图像精修分割以确定病灶特异性最佳SUVmin。
  • 所有病灶另用近期提出的阈值4.0分割,并比较所得体积。
  • 共分析61例患者的109个病灶:40个(37%)骨外、32个(29%)部分经骨、37个(34%)主要骨内。

主要发现

  • 病灶勾画的中位最佳SUVmin为4.2。
  • 骨受累未显著影响中位SUVmin(p=0.1)。
  • 个体化SUV体积与固定阈值4.0所得体积绝对一致性好(ICC[A,1]=0.967;95%CI:0.952-0.977;p<0.0001)。
  • 17个病灶(SUVmax<4.2)未被固定阈值捕获。
  • 16%的病灶(主要为很小的病灶)摄取减低,未被该阈值捕获。

关键数值与推荐

  • 固定阈值4.0与个体化SUVmin体积的绝对一致性ICC[A,1]=0.967(95%CI:0.952-0.977;p<0.0001)。
  • 病灶勾画的中位最佳SUVmin为4.2。
  • 骨受累对中位SUVmin无显著影响(p=0.1)。
  • 109个病灶中40个(37%)骨外、32个(29%)部分经骨、37个(34%)主要骨内。
  • 17个病灶(SUVmax<4.2)未被固定阈值4.0捕获。

临床怎么用

  • 原文结论认为所提出的SUV阈值4.0显示出有前景的结果,支持其适用于临床实践。
  • 原文结论同时指出16%的病灶(主要为很小的病灶)摄取减低而未被该阈值捕获,但强调其在临床实践中的适用性。

局限性

  • 原文结论指出虽然存在局限,16%的病灶(主要为很小的病灶)摄取减低而未被该阈值捕获。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Somatostatin receptor (SSTR)-targeted PET/CT provides valuable clinical insights beyond standard imaging in meningioma patients. Due to its excellent diagnostic capabilities and favorable logistics, the 18F-labeled SSTR-targeting peptide SiTATE is increasingly in demand. We aimed to validate a recently proposed standard uptake value (SUV) threshold for accurate meningioma delineation in a clinically diverse patient cohort, including complex anatomical locations and lesions with prior surgical intervention. METHODS: Consecutive patients with known or suspected meningioma who underwent [18F]SiTATE PET/CT and contrast enhanced cerebral MRI were included. Lesions were semi-automatically segmented on PET images using an individualized minimal SUV (SUVmin) within a manually defined volume of interest. Correlative CT and MRI images were used to refine segmentations for each lesion, identifying the optimal lesion-specific SUVmin to accurately capture the true volume of the meningioma. All lesions were additionally segmented using the recently proposed threshold of 4.0, and resulting volumes were compared. RESULTS: 61 patients with 109 lesions were analyzed: 40 (37%) extraosseous, 32 (29%) partial trans-osseous, and 37 (34%) predominantly intraosseous. The median optimal SUVmin for lesion delineation was 4.2. Osseous involvement did not significantly affect the median SUVmin (p = 0.1). Individualized SUV volumes showed excellent absolute agreement with those obtained using the fixed threshold of 4.0 (ICC[A,1] = 0.967; 95% CI: 0.952-0.977; p < 0.0001). However, 17 lesions (SUVmax < 4.2) were not captured by the fixed threshold. CONCLUSION: The proposed SUV threshold of 4.0 showed promising results, supporting its suitability for clinical practice. Although limitations were evident, with 16% of lesions - primarily very small - showing reduced uptake and therefore not captured by this threshold, the study underscores its applicability in clinical practice.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Mansour N, Joram J, Grawe F, et al. Validation of SUV thresholds in [¹⁸F]SiTATE PET/CT for accurate meningioma segmentation. Eur J Nucl Med Mol Imaging. 2025. PMID: 40699301. doi:10.1007/s00259-025-07476-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。